Death Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons. 2017

Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
Department of Biology, University of Virginia, Charlottesville, VA 22903, USA.

Axon degeneration during development is required to sculpt a functional nervous system and is also a hallmark of pathological insult, such as injury [1, 2]. Despite similar morphological characteristics, very little overlap in molecular mechanisms has been reported between pathological and developmental degeneration [3-5]. In the peripheral nervous system (PNS), developmental axon pruning relies on receptor-mediated extrinsic degeneration mechanisms to determine which axons are maintained or degenerated [5-7]. Receptors have not been implicated in Wallerian axon degeneration; instead, axon autonomous, intrinsic mechanisms are thought to be the primary driver for this type of axon disintegration [8-10]. Here we survey the role of neuronally expressed, paralogous tumor necrosis factor receptor super family (TNFRSF) members in Wallerian degeneration. We find that an orphan receptor, death receptor 6 (DR6), is required to drive axon degeneration after axotomy in sympathetic and sensory neurons cultured in microfluidic devices. We sought to validate these in vitro findings in vivo using a transected sciatic nerve model. Consistent with the in vitro findings, DR6-/- animals displayed preserved axons up to 4 weeks after injury. In contrast to phenotypes observed in Wlds and Sarm1-/- mice, preserved axons in DR6-/- animals display profound myelin remodeling. This indicates that deterioration of axons and myelin after axotomy are mechanistically distinct processes. Finally, we find that JNK signaling after injury requires DR6, suggesting a link between this novel extrinsic pathway and the axon autonomous, intrinsic pathways that have become established for Wallerian degeneration.

UI MeSH Term Description Entries
D009186 Myelin Sheath The lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem. Myelin,Myelin Sheaths,Sheath, Myelin,Sheaths, Myelin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001369 Axons Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. Axon
D014855 Wallerian Degeneration Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH. Degeneration, Wallerian
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018124 Receptors, Tumor Necrosis Factor Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells. Cachectin Receptors,TNF Receptors,Tumor Necrosis Factor Receptors,Receptors, Cachectin,Receptors, TNF,TNF Receptor,Tumor Necrosis Factor Receptor,Receptor, TNF
D019771 Axotomy Transection or severing of an axon. This type of denervation is used often in experimental studies on neuronal physiology and neuronal death or survival, toward an understanding of nervous system disease. Axotomies

Related Publications

Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
May 1995, Experimental neurology,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
July 1997, Experimental neurology,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
November 1991, Journal of neuropathology and experimental neurology,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
January 1960, Rivista di patologia nervosa e mentale,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
June 1967, Archives of neurology,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
August 1992, Neurologic clinics,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
March 1996, Bailliere's clinical neurology,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
January 2008, Neuroscience letters,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
April 2024, Cold Spring Harbor protocols,
Kanchana K Gamage, and Irene Cheng, and Rachel E Park, and Mardeen S Karim, and Kazusa Edamura, and Christopher Hughes, and Anthony J Spano, and Alev Erisir, and Christopher D Deppmann
December 1995, Experimental neurology,
Copied contents to your clipboard!